advertisement

WGA Rescources

Abstract #80034 Published in IGR 20-2

Vision-related Performance and Quality of Life of Patients With Rapid Glaucoma Progression

Waisbourd M; Sanvicente CT; Sanvicente CT; Coleman HM; Sieburth R; Zhan T; Gogte P; Muhire RSM; Wizov SS; Moster MR; Pro MJ; Fudemberg SJ; Mantravadi AV; Myers JS; Katz LJ; Hark LA; Spaeth GL
Journal of Glaucoma 2019; 28: 216-222


PURPOSE: The purpose of this study was to determine how clinical measures, performance-based measures and subjective assessments of vision-related quality of life (VRQoL) are affected in patients with rapid glaucoma progression. METHODS: Prospective longitudinal study that included 153 patients diagnosed with moderate glaucoma. A subset of patients that presented with rapid glaucoma progression (n=22), defined as visual field (VF) mean deviation (MD) loss >2.0 dB/y, were compared with patients with nonrapid progression (n=131). Groups were compared using t tests, χ, or Fisher exact test. Main outcome measures were visual acuity (VA), VF MD, retinal nerve fiber layer thickness (RNFL), contrast sensitivity (CS), Compressed Assessment of Ability Related to Vision (CAARV), and Rasch calibrated National Eye Institute Visual Function Questionnaire (NEI-VFQ-25) scores. RESULTS: At baseline, patients who progressed rapidly had lower measurements of VA (P=0.041), VF MD (P<0.001), Pelli-Robson score (P=0.004), Spaeth/Richman Contrast Sensitivity (SPARCS) score (P=0.001), RNFL thickness (P=0.009), CAARV total score (P<0.001), and NEI-VFQ-25 composite score (P=0.03). A multivariable logistic regression was performed and showed VF MD to be the only baseline independent predictor of rapid progression. After 1 year, patients who progressed rapidly also had a significant decrease in SPARCS score (P=0.04). CONCLUSIONS: Factors associated with rapid glaucoma progression included worse VF MD decreased scores of performance-based measures and subjectively worse VRQoL. After 1 year, rapid progressors had a significant reduction in contrast sensitivity as measured by SPARCS.

Full article

Classification:

1.4 Quality of life (Part of: 1 General aspects)
6.20 Progression (Part of: 6 Clinical examination methods)



Issue 20-2

Change Issue


advertisement

Topcon